Bayer Aktiengesellschaft (XTRA: BAYN)
Health Care · Pharmaceuticals · DE
€49.26
+1.61% today · +72.5% 1Y
Bayer Aktiengesellschaft (XTRA: BAYN) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $55.58B and employs 87,830 people.
Over the last twelve months the share price has gained 72.5%, trading between 25.78 and 53.92.
Tweenvest scores Bayer Aktiengesellschaft across four factors: quality 65/100, value 49/100, growth 29/100, dividend 4/100. Its strongest factor is quality.
BAYN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $55.58B
- Revenue (TTM)
- $51.84B
- P/E
- —
- EPS
- -1.77
- Dividend yield
- 0.23%
- Beta (5Y)
- 0.83
- 52-week high
- €53.92
- 52-week low
- €25.78
- Avg volume (3M)
- —
- Shares outstanding
- 982.42M
- Employees
- 87,830
- Next earnings
- —
About Bayer Aktiengesellschaft
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
- ISIN
- DE000BAY0017
- Founded
- 1863
- Listed since
- Dec 16, 1996
- Exchange
- XETRA Trading Platform
- Currency
- EUR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,243.15 | -0.30% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.25 | +0.08% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $156.17 | +3.66% |
| Roche Holding AGSWX: ROP | $368.80B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.51 | +1.93% |
Figures last refreshed Aug 18, 2026.